Navigation Links
Ira Haimowitz, PhD, EVP, at The CementBloc, to Present on Best Practices in iPad Interactive Selling at 11th Annual ePharma Summit™
Date:1/26/2012

NEW YORK, Jan. 26, 2012 /PRNewswire/ -- Dr. Ira J. Haimowitz, Executive Vice President, Group Director, Intelligence and Analytics, at The CementBloc, will be a featured presenter at the eMarketing University for Brand Managers, a symposium at the ePharma Summit in New York City on February 6, 2012.

The symposium is a full-day course designed for those in pharmaceutical product management seeking to incorporate digital tactics into their marketing mix. Dr. Haimowitz will be presenting on the benefits of transitioning to closed-loop, iPad-based detailing. His talk is entitled, "Transforming Your Organization Through Interactive Selling." He will bring to the symposium his unique expertise in the use of technology in pharmaceutical sales and marketing.

"Selling with an iPad represents a cultural shift," explains Dr. Haimowitz. "It is critical to ensure processes are in place to rapidly respond to changing market needs and keep content fresh. This kind of agility will require the commitment and active participation by several groups of stakeholders: sales and sales leadership, sales operations, sales training, marketing, marketing science and market research, IT, medical/legal/regulatory, and potentially sourcing and vendor management."

For over 20 years, Dr. Haimowitz has provided healthcare clients with innovative solutions for relationship marketing, segmentation, operations, measurement, and optimization. He has also enabled clients to evaluate the return on investment of their multichannel consumer and professional advertising campaigns.

Prior to joining The CementBloc, Dr. Haimowitz spent nearly 10 years on the manufacturer side as a Director and Team Leader in marketing and sales operations and analytics for pharmaceutical companies Pfizer and Organon. He then served as Vice President, Group Director of Insights and Optimization, at Wunderman, leading a team deploying analytics across healthcare, financial services, and consumer pa
'/>"/>

SOURCE The CementBloc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ira Haimowitz, PhD, EVP, Group Director, Intelligence and Analytics at The CementBloc, to Present at Aberdeen Group Inaugural Business Analytics Summit
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
6. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
9. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
10. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
11. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 30, 2014  InnoPharma, Inc. today announced the first ... equivalent of Zyprexa® injection), in Canada.  Olanzapine is indicated ... in patients with schizophrenia or bipolar I mania. ... InnoPharma has entered into an agreement with Sandoz Canada ... make, use, sell, market and distribute Olanzapine Injection in ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
(Date:7/30/2014)... and NEW YORK , July ... a developer of new products for oncology supportive care, ... ® , has been featured in an article on ... Symptoms in Head and Neck Cancers."  Dr. Steve ... insight on the growing demand seen in the oncology ...
Breaking Medicine Technology:InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President and ... Sachs Global Healthcare Conference on Tuesday, June 15 , at ... Los Angeles .  The presentation will be webcast on the following ... , ...
... Epocal, Inc., a leading edge provider of point ... Food and Drug Administration (FDA) clearance to market its new ... from the epoc System are used to evaluate acid-base status ... acidity of the blood).  The addition of lactate to the ...
Cached Medicine Technology:Epocal Announces FDA Clearance of Lactate Test 2
(Date:7/30/2014)... The Restore My Blood Sugar review recently published ... levels can now find an amazingly successful method of reducing ... created by D. Chao and Andrew Forester who claim that ... it comes to normalizing blood sugar levels. Chao actually is ... to the cure of diabetes that all patients should find ...
(Date:7/30/2014)... July 30, 2014 New changes are in ... plans to move to a new facility. The official date ... will be moving soon. , MedX Pharmacy will be moving ... Pearland, TX 77581. This is the old Wells Fargo building. ... and will include a drive thru for convenient drop-off and ...
(Date:7/30/2014)... Conducting Advanced Root Cause Analysis ... and Innovative Techniques to Improve the Quality of ... Sept. 17-18, 2014 – Raleigh, NC, http://www.fdanews.com/CAPAWorkshopRaleigh ... for 483 observations since 1997. , The FDA's ... CAPA program has never been more important. , ...
(Date:7/30/2014)... drug to treat malaria, is now widespread throughout ... ( P. falciparum ) parasites that cause the ... mutation in the parasites. However, a six-day course ... three-day coursehas proved highly effective in treating drug-resistant ... the New England Journal of Medicine . ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- It can happen in ... television, dresser or computer monitor and gets critically injured when ... a young child should look around their homes and imagine ... child. Imagining it is better than it becoming a reality," ... Physicians, said in a college news release. Between 2009 ...
Breaking Medicine News(10 mins):Health News:Restore My Blood Sugar Review Reveals Exclusive Ways to Normalize Blood Sugar 2Health News:MedX Pharmacy Relocates to New Facility 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 2Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 3Health News:FDAnews Workshop: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 17-18, 2014, Raleigh, NC 4Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Tip-Over Furniture Can Kill Kids 2
... WASHINGTON and DUBLIN , March ... Ireland -based, physician-led global certification company, today announced that ... Mark on its new LuV300 vacuum with Kompressor® technology. ... range of products from worldwide manufacturers to determine their ...
... ... , ... ... On Thursday, March 18 , lawyers from the U.S. Department of Justice will appear in Federal District ...
... Care to Pay for It Makes Little Sense , ... ... PRINCETON, N.J. , March 16 Statement ... , , ...
... and suffering caused by antibiotic-resistant bacterial infections continue to rise ... (IDSA) is urging a global commitment to develop 10 new ... to address this public health crisis and safeguard patients, health. ... a statementpublished in the April 15 issue of Clinical ...
... has long been identified as a risk factor for cardiovascular ... researchers at the University of Rochester Medical Center found that ... risk of dying suddenly from cardiac causes. Scientists found ... underweight patients had a 76 percent increase in risk ...
... ... a new laundry detergent for U.S. consumers concerned about their budget as well as ... contains 10 ounces of macro-molecule laundry detergent which cleans for up to 12 months ... over 200 washes. , ...
Cached Medicine News:Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 2Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 3Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 4Health News:Ireland's Allergy Standards Limited Adds LG Electronics to Host of Companies Making Allergy-Certified Consumer Products 5Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 2Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 3Health News:Court Hearing Thursday on Physicians' Challenge to 'Obamacare': Doctors Argue Against 'Arbitrary Power and Tyranny' 4Health News:NJHA: Charity Care Must Be a Priority as Uninsured Burden Grows 2Health News:ID physicians call for 10 new antibiotics by 2020 2Health News:As girth grows, risk of sudden cardiac death shrinks 2Health News:As girth grows, risk of sudden cardiac death shrinks 3Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 2Health News:Oransi Launches Robby Wash High Efficiency Laundry Detergent in U.S. – 10 Ounces Replaces 75 lbs. of Traditional Laundry Detergent 3
Ideal for chemical processing that requires downward flow of exhaust fumes. Powderful 1200 CFM blower draws fumes into sub-surface bonded charcoal filter for safe removal of organic vapors (final HEP...
... benchtop fume hood ventilates and ... indoor release of exhaust. Bonded ... contaminants. Configurations are available with ... include final HEPA filter, work ...
... proof polypropylene exhaust hoods are designed to ... and draw a stream of air across ... the operator. Other sizes and types of ... double-slot are available on special order in ...
... Benchtop Fume Hood is an economical unit ... which a number of fume hoods are ... colleges and universities. Features include a one-piece ... rounded inside corners for easy cleaning. A ...
Medicine Products: